Report on the 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy - September 24-26, 2015, Ottawa, Canada

Overview

Journal J Neuromuscul Dis

Publisher Sage Publications

Specialty Neurology

Date 2016 Nov 18

PMID 27854234

Authors

Jodi Warman Chardon

Bernard J Jasmin

Rashmi Kothary

Robin J Parks

Affiliations

Soon will be listed here.

References

Harper S, Hauser M, Dellorusso C, Duan D, Crawford R, Phelps S . Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med. 2002; 8(3):253-61. DOI: 10.1038/nm0302-253. View

Barresi R, Michele D, Kanagawa M, Harper H, Dovico S, Satz J . LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med. 2004; 10(7):696-703. DOI: 10.1038/nm1059. View

Gregorevic P, Blankinship M, Allen J, Crawford R, Meuse L, Miller D . Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med. 2004; 10(8):828-34. PMC: 1365046. DOI: 10.1038/nm1085. View

Kirby J, Halligan E, Baptista M, Allen S, Heath P, Holden H . Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain. 2005; 128(Pt 7):1686-706. DOI: 10.1093/brain/awh503. View

Grondard C, Biondi O, Armand A, Lecolle S, Della Gaspera B, Pariset C . Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci. 2005; 25(33):7615-22. PMC: 6725405. DOI: 10.1523/JNEUROSCI.1245-05.2005. View

Laberge A, Michaud J, Richter A, Lemyre E, Lambert M, Brais B . Population history and its impact on medical genetics in Quebec. Clin Genet. 2005; 68(4):287-301. DOI: 10.1111/j.1399-0004.2005.00497.x. View

Greenberg S, Bradshaw E, Pinkus J, Pinkus G, Burleson T, Due B . Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology. 2005; 65(11):1782-7. DOI: 10.1212/01.wnl.0000187124.92826.20. View

Greenberg S . A gene expression approach to study perturbed pathways in myositis. Curr Opin Rheumatol. 2007; 19(6):536-41. DOI: 10.1097/BOR.0b013e3282efe261. View

Gueneau L, Bertrand A, Jais J, Salih M, Stojkovic T, Wehnert M . Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2009; 85(3):338-53. PMC: 2771595. DOI: 10.1016/j.ajhg.2009.07.015. View

10.

Zucconi E, Costa Valadares M, Vieira N, Bueno Jr C, Secco M, Jazedje T . Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog. Neuromuscul Disord. 2009; 20(1):64-70. DOI: 10.1016/j.nmd.2009.10.011. View

11.

Joe A, Yi L, Natarajan A, Le Grand F, So L, Wang J . Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol. 2010; 12(2):153-63. PMC: 4580288. DOI: 10.1038/ncb2015. View

12.

Seenundun S, Rampalli S, Liu Q, Aziz A, Palii C, Hong S . UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. EMBO J. 2010; 29(8):1401-11. PMC: 2868576. DOI: 10.1038/emboj.2010.37. View

13.

Pestronk A . Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol. 2011; 23(6):595-604. DOI: 10.1097/BOR.0b013e32834bab42. View

14.

Stark D, Karvas R, Siegel A, Cornelison D . Eph/ephrin interactions modulate muscle satellite cell motility and patterning. Development. 2011; 138(24):5279-89. PMC: 3222207. DOI: 10.1242/dev.068411. View

15.

Cardani R, Giagnacovo M, Botta A, Rinaldi F, Morgante A, Udd B . Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. J Neurol. 2012; 259(10):2090-9. DOI: 10.1007/s00415-012-6462-1. View

16.

Ravel-Chapuis A, Belanger G, Yadava R, Mahadevan M, DesGroseillers L, Cote J . The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing. J Cell Biol. 2012; 196(6):699-712. PMC: 3308689. DOI: 10.1083/jcb.201108113. View

17.

Wheeler T, Leger A, Pandey S, MacLeod A, Nakamori M, Cheng S . Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 2012; 488(7409):111-5. PMC: 4221572. DOI: 10.1038/nature11362. View

18.

Jones K, Wei C, Iakova P, Bugiardini E, Schneider-Gold C, Meola G . GSK3β mediates muscle pathology in myotonic dystrophy. J Clin Invest. 2012; 122(12):4461-72. PMC: 3533547. DOI: 10.1172/JCI64081. View

19.

Higgs B, Zhu W, Morehouse C, White W, Brohawn P, Guo X . A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. Ann Rheum Dis. 2013; 73(1):256-62. PMC: 3888620. DOI: 10.1136/annrheumdis-2012-202794. View

20.

Antonicka H, Sasarman F, Nishimura T, Paupe V, Shoubridge E . The mitochondrial RNA-binding protein GRSF1 localizes to RNA granules and is required for posttranscriptional mitochondrial gene expression. Cell Metab. 2013; 17(3):386-98. DOI: 10.1016/j.cmet.2013.02.006. View